Journal of the National Cancer Institute Q1 Unclaimed

Oxford University Press United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of the National Cancer Institute is a journal indexed in SJR in Oncology and Cancer Research with an H index of 377. Journal with a Single blind Peer Review review system, and It has a price of 3578 €. The scope of the journal is focused on Cancer, Medicine. It has an SJR impact factor of 5,409 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 5,409.

Journal of the National Cancer Institute focuses its scope in these topics and keywords: cancer, breast, prostate, clinical, receptor, bite, lung, controlled, risk, sex, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


3578 €

Inmediate OA


Embargoed OA

0 €

Non OA


Journal of the National Cancer Institute


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

cancer, breast, prostate, clinical, receptor, bite, lung, controlled, risk, sex, age, growth, therapy, deaths, group, patients, inhibitor, melanoma, mortality, node, nonmetastatic, hormones, function, factor, Cancer, Medicine

Best articles by citations

For Telomeres, Longer Is Not Always Better

View more

Relationship of Leukemia Risk to Radiation Dose Following Cancer of the Uterine Corpus

View more

Helicobacter pylori Seroprevalence and Colorectal Neoplasia: Evidence Against an Association

View more

Chromosomal Abnormalities in Patients With Hodgkin's Disease: Evidence for Frequent Involvement of the 14q Chromosomal Region but Infrequent bcl-2 Gene Rearrangement in Reed-Sternberg Cells

View more

Risk of Transfusion-Associated Transmission of Human Herpesvirus 8

View more

In Different Cultures, Cancer Screening Presents Challenges

View more

Evaluation of Bias in Familial Risk Estimates: A Study of Common Cancers Using Swedish Population-based Registers

View more

Gender- and Smoking-Related Bladder Cancer Risk

View more

Prostate Cancer Screening at National Cancer Institute Comprehensive and Clinical Cancer Centers

View more

Psychosocial Care Integral for Breast Cancer Patients, Report Concludes

View more

Protein N-Myristoylation as a Chemotherapeutic Target for Cancer

View more

For Whom the Bell Tolls: Susceptibility to Common Adult Cancers in Retinoblastoma Survivors

View more

Common Threads of Mucosa-Associated Lymphoid Tissue Lymphoma Pathogenesis: From Infection to Translocation

View more

Brief Communication: B-Cell Origin of Hamster Lymphoid Tumors Induced by Simian Virus 40

View more

Burkitt's Lymphoma in the Mengo Districts of Uganda: Epidemiologic Features and Their Relationship to Malaria

View more

Suppression of Metastasis--A New Function for Known Proteins

View more

Norwegian Law Brings Alternative Medicine to the Mainstream

View more

As Targeted Therapies Evolve, Challenges Remain

View more

Xenografts Raise Questions About Cancer Virus Transfer to Humans

View more

Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations

View more

Male Breast Cancer During Finasteride Therapy

View more

Press Release: Active Smoking Associated With Increased Risk of Breast Cancer

View more

Funding Cuts for Public Health Projects in Europe May Affect International Cancer Effort

View more

Press Release: Aspirin Use May Be Associated With Increased Risk of Pancreatic Cancer

View more